Treatment strategies for comorbid conditions lower residual risk in patients with treated hypertension: FOURIER and other randomized outcome trials

被引：2
|
作者：
Kjeldsen, Sverre E. [1 ]
Narkiewicz, Krzysztof [2 ]
Burnier, Michel [3 ]
Oparil, Suzanne [4 ]
机构：
[1] Univ Oslo, Ullevaal Hosp, Dept Cardiol, Oslo, Norway
[2] Med Univ Gdansk, Dept Hypertens & Diabetol, Gdansk, Poland
[3] CHU Vaudois, Serv Nephrol & Hypertens, Lausanne, Switzerland
[4] Univ Alabama Birmingham, Dept Med, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA
来源：
BLOOD PRESSURE | 2017年 / 26卷 / 05期
关键词：
BLOOD-PRESSURE; ATRIAL-FIBRILLATION; PREVENTION; WARFARIN; DISEASE;
D O I：
10.1080/08037051.2017.1357110
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：257 / 258
页数：2
相关论文
共 20 条
  • [1] Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials
    Bossi, Paolo
    Miceli, Rosalba
    Benasso, Marco
    Corvo, Renzo
    Bacigalupo, Andrea
    Sanguineti, Giuseppe
    Fallai, Carlo
    Merlano, Marlo C.
    Infante, Gabriele
    Dani, Carla
    Di Giannantonio, Valerio
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (12): : 2648 - 2656
  • [2] Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials
    Bejan-Angoulvant, Theodora
    Saadatian-Elahi, Mitra
    Wright, James M.
    Schron, Eleanor B.
    Lindholm, Lars H.
    Fagard, Robert
    Staessen, Jan A.
    Gueyffier, Francois
    JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1366 - 1372
  • [3] Need for multiple risk reduction strategies in clinical trials enrolling high risk patients - FOURIER investigating PCSK-9 inhibitor to lower cholesterol revisited
    Kjeldsen, Sverre E.
    Narkiewicz, Krzysztof
    Burnier, Michel
    Oparil, Suzanne
    BLOOD PRESSURE, 2019, 28 (03) : 144 - 145
  • [4] Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
    Strangfeld, A.
    Richter, A.
    Siegmund, B.
    Herzer, P.
    Rockwitz, K.
    Demary, W.
    Aringer, M.
    Meissner, Y.
    Zink, A.
    Listing, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 504 - 510
  • [5] A systematic review and meta-analysis of randomized controlled trials to evaluate the risk of hypophosphatemia, hypertension, and hematological toxicities in patients with cancer treated with regorafenib.
    Igid, Henry Palangdao
    Thein, Kyaw Zin
    Sultan, Anita
    Swarup, Sriman
    Awasthi, Sanjay
    Jones, Catherine
    Hardwicke, Fred L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Individual patient data meta-analysis of the impact of treatment expertise on the outcome of head and neck cancer patients treated within 6 randomized trials
    Bossi, P.
    Miceli, R.
    Benasso, M.
    Corvo, R.
    Bacigalupo, A.
    Sanguineti, G.
    Fallai, C.
    Merlano, M. C.
    Infante, G.
    Dani, C.
    Di Giannantonio, V.
    Licitra, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Individual patient data meta-analysis of the IMPACT of treatment site on the outcome of head and neck cancer patients treated within 6 randomized trials.
    Bossi, Paolo
    Miceli, Rosalba
    Benasso, Marco
    Corvo, Renzo
    Bacigalupo, Almalina
    Sanguineti, Giuseppe
    Fallai, Carlo
    Merlano, Marco Carlo
    Infante, Gabriele
    Dani, Carla
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk - overviewand meta-analyses of randomized trials
    Thomopoulos, Costas
    Parati, Gianfranco
    Zanchetti, Alberto
    JOURNAL OF HYPERTENSION, 2014, 32 (12) : 2305 - 2314
  • [9] Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with breast cancer treated with HER2 blockade
    Wu, Junyan
    Qiu, Kaifeng
    Zhu, Jianhong
    Li, Jianfang
    Lin, Yin
    He, Zhichao
    Li, Guocheng
    BREAST, 2015, 24 (06): : 699 - 704
  • [10] Incidence and risk of treatment-related mortality in cancer patients treated with EGFR-TKIs: A meta-analysis of 22 phase III randomized controlled trials
    Qi, Wei-Xiang
    Tang, Li-Na
    He, Ai-Na
    Yao, Yang
    Shen, Zan
    RESPIRATORY MEDICINE, 2013, 107 (08) : 1280 - 1283
12